PL3334454T3 - Kompozycje mycoplasma bovis - Google Patents

Kompozycje mycoplasma bovis

Info

Publication number
PL3334454T3
PL3334454T3 PL16757118.1T PL16757118T PL3334454T3 PL 3334454 T3 PL3334454 T3 PL 3334454T3 PL 16757118 T PL16757118 T PL 16757118T PL 3334454 T3 PL3334454 T3 PL 3334454T3
Authority
PL
Poland
Prior art keywords
compositions
mycoplasma bovis
bovis
mycoplasma
bovis compositions
Prior art date
Application number
PL16757118.1T
Other languages
English (en)
Inventor
Glenn Francis Browning
Philip Francis Markham
Marc Serge Marenda
Fred H. Weber
Suman MAHAN
Original Assignee
Zoetis Services Llc
The University Of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc, The University Of Melbourne filed Critical Zoetis Services Llc
Publication of PL3334454T3 publication Critical patent/PL3334454T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
PL16757118.1T 2015-08-14 2016-08-11 Kompozycje mycoplasma bovis PL3334454T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205125P 2015-08-14 2015-08-14
PCT/US2016/046572 WO2017030901A1 (en) 2015-08-14 2016-08-11 Mycoplasma bovis compositions

Publications (1)

Publication Number Publication Date
PL3334454T3 true PL3334454T3 (pl) 2023-01-30

Family

ID=56800367

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16757118.1T PL3334454T3 (pl) 2015-08-14 2016-08-11 Kompozycje mycoplasma bovis

Country Status (22)

Country Link
US (2) US11389518B2 (pl)
EP (2) EP3334454B1 (pl)
JP (1) JP6675484B2 (pl)
CN (3) CN115141773A (pl)
AU (2) AU2016307935B2 (pl)
BR (1) BR112018002919B1 (pl)
CA (1) CA2995101A1 (pl)
DK (1) DK3334454T3 (pl)
ES (1) ES2933623T3 (pl)
FI (1) FI3334454T3 (pl)
FR (1) FR23C1037I1 (pl)
HK (1) HK1251478A1 (pl)
HR (1) HRP20221440T1 (pl)
HU (2) HUE060545T2 (pl)
LT (1) LT3334454T (pl)
MX (1) MX2018001841A (pl)
NL (1) NL301244I2 (pl)
PL (1) PL3334454T3 (pl)
PT (1) PT3334454T (pl)
SI (1) SI3334454T1 (pl)
WO (1) WO2017030901A1 (pl)
ZA (1) ZA201800956B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN111471695A (zh) * 2020-05-11 2020-07-31 吉林农业大学 牛支原体免疫磁珠的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
WO1992015672A1 (en) 1991-03-07 1992-09-17 Virogenetics Corporation Genetically engineered vaccine strain
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
JPH07507854A (ja) 1991-12-23 1995-08-31 ツォッヒェ，ミヒャエル 油除去装置を備えたエンジン
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
TR199801702T2 (xx) 1996-02-28 1998-12-21 Bayer Aktiengesellschaft Yabanc� DNA ihtiva eden parapoksvir�sler, bunlar�n haz�rlanmas� ve a��larda kullan�m�.
KR20070108418A (ko) 1996-10-23 2007-11-09 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 면역 치료법 및 개량 백신
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
KR100743894B1 (ko) 1998-02-27 2007-07-30 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 백신, 면역치료제 및 그의 이용 방법
EP1061955B1 (en) 1998-03-13 2005-05-04 Wyeth Polynucleotide composition, method of preparation, and use thereof
CA2344740C (en) 1998-09-30 2011-11-22 American Cyanamid Company Mutant cholera holotoxin as an adjuvant
IL149471A0 (en) 1999-11-08 2002-11-10 Biomune Vaccines for mycoplasma bovis and methods for immunizing bovine amimals
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
GB0110851D0 (en) 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
WO2002098369A2 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
ATE451386T1 (de) 2001-06-07 2009-12-15 Wyeth Corp Mutantenformen von cholera holotoxin als adjuvans
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP2363493B1 (en) 2003-02-20 2012-11-14 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
CA2729080C (en) 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
CA2740954C (en) * 2008-10-31 2018-09-25 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine composition
CA2750136A1 (en) * 2009-02-20 2010-08-26 Australian Poultry Crc Pty Limited Live attenuated vaccines
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
BR112018002919A2 (pt) 2018-09-18
PT3334454T (pt) 2022-12-20
MX2018001841A (es) 2018-08-01
DK3334454T3 (da) 2022-11-14
EP3334454B1 (en) 2022-10-19
US20220296694A1 (en) 2022-09-22
ZA201800956B (en) 2018-12-19
AU2016307935B2 (en) 2022-08-18
HUS2300032I1 (hu) 2023-10-28
FI3334454T3 (fi) 2023-01-13
EP3334454A1 (en) 2018-06-20
HUE060545T2 (hu) 2023-03-28
BR112018002919B1 (pt) 2024-02-27
CN108135989A (zh) 2018-06-08
US11389518B2 (en) 2022-07-19
CN115141773A (zh) 2022-10-04
HK1251478A1 (zh) 2019-02-01
NL301244I1 (nl) 2023-10-04
WO2017030901A1 (en) 2017-02-23
ES2933623T3 (es) 2023-02-10
CN115141772A (zh) 2022-10-04
EP4137152A1 (en) 2023-02-22
AU2022231761A1 (en) 2022-10-06
FR23C1037I1 (fr) 2023-12-08
LT3334454T (lt) 2022-12-27
CA2995101A1 (en) 2017-02-23
CN108135989B (zh) 2022-08-09
SI3334454T1 (sl) 2023-02-28
HRP20221440T1 (hr) 2023-02-03
AU2016307935A1 (en) 2018-02-22
JP6675484B2 (ja) 2020-04-01
NL301244I2 (nl) 2023-11-01
JP2018523708A (ja) 2018-08-23
US20190255166A1 (en) 2019-08-22

Similar Documents

Publication Publication Date Title
SG11201705415YA (en) Multi-supplement compositions
IL257131A (en) Preparations
HK1251559A1 (zh) 普那布林組合物
GB201501598D0 (en) Compositions
GB201505527D0 (en) Composition
GB201506827D0 (en) Composition
GB201515387D0 (en) Compositions
GB201515391D0 (en) Compositions
GB201506829D0 (en) Composition
GB201506830D0 (en) Composition
HUS2300032I1 (hu) Mycoplasma bovis-készítmények
GB201506825D0 (en) Composition
SI3349766T1 (sl) Antihemoragični sestavki
GB201508510D0 (en) Curling compositions
GB201506828D0 (en) Composition
GB201505520D0 (en) Composition
GB201504665D0 (en) Composition
GB201504307D0 (en) Composition
GB2538335B (en) Compositions
GB201508722D0 (en) Composition
GB201506826D0 (en) Composition
HUE050837T2 (hu) Készítmények
GB201522892D0 (en) Compositions
GB201511469D0 (en) Compositions
GB201507673D0 (en) Compositions